IsproniclineA novel α4β2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties

被引：0

作者：

Patrick Lippiello

Sharon R. Letchworth

Gregory J. Gatto

Vincent M. Traina

Merouane Bencherif

机构：

[1] Targacept,Preclinical Research

[2] Inc.,undefined

来源：

Journal of Molecular Neuroscience | 2006年 / 30卷

关键词：

Nicotinic Acetylcholine Receptor; Molecular Neuroscience Volume; Striatal Dopamine Release; Neuronal nAChR; nAChR Agonist;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：19 / 20

页数：1

共 50 条

[41] ABT-418, a selective α4β2 nicotinic acetylcholine receptor agonist, ameliorates psychiatric symptoms induced by pentylenetetrazol-kindled mice
Takechi, Kenshi
Tanaka, Akihiro
Araki, Hiroaki
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S94 - S94
[42] CEP-26401 (Irdabisant), a Potent and Selective Histamine H3 Receptor Antagonist/Inverse Agonist with Cognition-Enhancing and Wake-Promoting Activities
Raddatz, Rita
Hudkins, Robert L.
Mathiasen, Joanne R.
Gruner, John A.
Flood, Dorothy G.
Aimone, Lisa D.
Le, Siyuan
Schaffhauser, Herve
Duzic, Emir
Gasior, Maciej
Bozyczko-Coyne, Donna
Marino, Michael J.
Ator, Mark A.
Bacon, Edward R.
Mallamo, John P.
Williams, Michael
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 340 (01): : 124 - 133
[43] Identification and in vitro pharmacological characterization of a novel and selective α7 nicotinic acetylcholine receptor agonist, Br-IQ17B
Jing-shu Tang
Bing-xue Xie
Xi-ling Bian
Yu Xue
Ning-ning Wei
Jing-heng Zhou
Yu-chen Hao
Gang Li
Liang-ren Zhang
Ke-wei Wang
Acta Pharmacologica Sinica, 2015, 36 : 800 - 812
[44] Identification and in vitro pharmacological characterization of a novel and selective α7 nicotinic acetylcholine receptor agonist, Br-IQ17B
Tang, Jing-shu
Xie, Bing-xue
Bian, Xi-ling
Xue, Yu
Wei, Ning-ning
Zhou, Jing-heng
Hao, Yu-chen
Li, Gang
Zhang, Liang-ren
Wang, Ke-wei
ACTA PHARMACOLOGICA SINICA, 2015, 36 (07) : 800 - 812
[45] Varenicline, a selective α4β2 nicotinic receptor agonist, is effective in persistent pain models in rats
Sher, E.
Zwart, R.
Li, D. L.
Simmons, R. M. A.
Peters, S. C.
Folly, E. A.
Mogg, A. J.
Broad, L. M.
Iyengar, S.
BIOCHEMICAL PHARMACOLOGY, 2007, 74 (08) : SMA40 - SMA40
[46] Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid
Rollema, H.
Chambers, L. K.
Coe, J. W.
Glowa, J.
Hurst, R. S.
Lebel, L. A.
Lu, Y.
Mansbach, R. S.
Mather, R. J.
Rovetti, C. C.
Sands, S. B.
Schaeffer, E.
Schulz, D. W.
Tingley, F. D., III
Williams, K. E.
NEUROPHARMACOLOGY, 2007, 52 (03) : 985 - 994
[47] Efficacy and safety of varenicline, an α4β2 acetylcholine nicotinic receptor partial agonist, for smoking cessation in Japanese smokers
Nakamura, Masakazu
Fujimoto, Yoko
Maruyama, Nami
Ishibashi, Taro
Reeves, Karen
CIRCULATION, 2006, 114 (18) : 856 - 856
[48] Metabolism and disposition of varenicline, a selective α4β2 acetylcholine receptor partial agonist, in vivo and in vitro
Obach, RS
Reed-Hagen, AE
Krueger, SS
Obach, BJ
O'Connell, TN
Zandi, KS
Miller, S
Coe, JW
DRUG METABOLISM AND DISPOSITION, 2006, 34 (01) : 121 - 130
[49] Differential α4(+)/(-)β2 Agonist-binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function within and between Isoforms
Lucero, Linda M.
Weltzin, Maegan M.
Eaton, J. Brek
Cooper, John F.
Lindstrom, Jon M.
Lukas, Ronald J.
Whiteaker, Paul
JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (05) : 2444 - 2459
[50] Selective Potentiation of the (α4)3(β2)2 Nicotinic Acetylcholine Receptor Response by NS9283 Analogues
Appiani, Rebecca
Viscarra, Franco
Biggin, Philip C.
Bermudez, Isabel
Giraudo, Alessandro
Pallavicini, Marco
Bolchi, Cristiano
ACS CHEMICAL NEUROSCIENCE, 2024, 15 (07): : 1501 - 1514

← 1 2 3 4 5 →